Abstract
Aim:
To investigate the effects of ROS scavenger N-acetylcysteine (NAC) on angiotensin II (Ang II)-mediated renal fibrosis in vivo and in vitro.
Methods:
Mice were subjected to unilateral ureteral obstruction (UUO), and then treated with vehicle or NAC (250 mg/kg, ip) for 7 days. Histological changes of the obstructed kidneys were observed with Masson's trichrome staining. ROS levels were detected with DHE staining. The expression of relevant proteins in the obstructed kidneys was assessed using Western blotting assays. Cultured rat renal fibroblast NRK-49F cells were used for in vitro experiments.
Results:
In the obstructed kidneys, Ang II levels were significantly elevated, and collagen I was accumulated in the interstitial spaces. Furthermore, ROS production and the expression of p47 (a key subunit of NADPH oxidase complexes) were increased in a time-dependent manner; the expression of fibronectin, α-SMA and TGF-β were upregulated. Administration of NAC significantly alleviated the fibrotic responses in the obstructed kidneys. In cultured NRK-49F cells, treatment with Ang II (0.001–10 μmol/L) increased the expression of fibronectin, collagen I, α-SMA and TGF-β in dose-dependent and time-dependent manners. Ang II also increased ROS production and the phosphorylation of Smad3. Pretreatment with NAC (5 μmol/L) blocked Ang II-induced oxidative stress and ECM production in the cells.
Conclusion:
In mouse obstructed kidneys, the fibrotic responses result from Ang II upregulation can be alleviated by the ROS scavenger N-acetylcysteine.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Liu Y . Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 2011; 7: 684–96.
Snyder JJ, Foley RN, Collins AJ . Prevalence of CKD in the United States: a sensitivity analysis using the National Health and Nutrition Examination Survey (NHANES) 1999–2004. Am J Kidney Dis 2009; 53: 218–28.
Crowley SD, Coffman TM . Recent advances involving the renin-angiotensin system. Exp Cell Res 2012; 318: 1049–56.
Ucero AC, Goncalves S, Benito-Martin A, Santamaria B, Ramos AM, Berzal S, et al. Obstructive renal injury: from fluid mechanics to molecular cell biology. Open Access J Urol 2010; 2: 41–55.
Santos P, Krieger JE, Pereira AC . Renin angiotensin system, hypertension; and chronic kidney disease: pharmacogenetic implications. J Pharmacol Sci 2012; 120: 77–88.
Uchida Y, Miyajima A, Kikuchi E, Kozakai N, Kosaka T, Ieda M, et al. Renal damage inhibited in mice lacking angiotensinogen gene subjected to unilateral ureteral obstruction. Urology 2009; 74: 938–43.
Jung GS, Jeon JH, Jung YA, Choi YK, Kim HS, Kim JG, et al. Clusterin/apolipoprotein J attenuates angiotensin II-induced renal fibrosis. PLoS One 2014; 9: e105635.
Xia YF, Jin XG, Yan JY, Entman ML, Wang YL . CXCR6 plays a critical role in angiotensin II-induced renal injury and fibrosis. Arterioscler Thromb Vasc Biol 2014; 34: 1422.
Chow B, Kocan M, Bosnyak S, Sarwar M, Wigg B, Jones ES, et al. Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis. Kidney Int 2014; 86: 75–85.
Ruster C, Wolf G . Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis. J Am Soc Nephrol 2011; 22: 1189–99.
Kagami S . Involvement of glomerular renin-angiotensin system (RAS) activation in the development and progression of glomerular injury. Clin Exp Nephrol 2012; 16: 214–20.
Navarro-Yepes J, Burns M, Anandhan A, Khalimonchuk O, Del Razo LM, Quintanilla-Vega B, et al. Oxidative stress, redox signaling, and autophagy: cell death versus survival. Antioxid Redox Sign 2014; 21: 66–85.
Schieber M, Chandel NS . ROS function in redox signaling and oxidative stress. Curr Biol 2014; 24: R453–62.
Brandes RP, Weissmann N, Schroder K . Redox-mediated signal transduction by cardiovascular Nox NADPH oxidases. J Mol Cell Cardiol 2014; 73: 70–9.
Rhee SG . H2O2, a necessary evil for cell signaling. Science 2006; 312: 1882–3.
Okamura DM, Pennathur S . The balance of powers: Redox regulation of fibrogenic pathways in kidney injury. Redox Biol 2015; 6: 495–504.
Sedeek M, Nasrallah R, Touyz RM, Hebert RL . NADPH oxidases, reactive oxygen species, and the kidney: friend and foe. J Am Soc Nephrol 2013; 24: 1512–8.
Abdo S, Zhang SL, Chan JS . Reactive oxygen species and nuclear factor erythroid 2-related factor 2 activation in diabetic nephropathy: a hidden target. J Diabetes Metab 2015; 6. doi: 10.4172/2155-6156.100547.
Hirata Y, Yamamoto E, Tokitsu T, Fujisue K, Kurokawa H, Sugamura K, et al. The pivotal role of a novel biomarker of reactive oxygen species in chronic kidney disease. Medicine (Baltimore) 2015; 94: e1040.
Ni J, Shen Y, Wang Z, Shao DC, Liu J, Kong YL, et al. P300-dependent STAT3 acetylation is necessary for angiotensin II-induced pro-fibrotic responses in renal tubular epithelial cells. Acta Pharmacol Sin 2014; 35: 1157–66.
Deiana L, Carru C, Pes G, Tadolini B . Spectrophotometric measurement of hydroperoxides at increased sensitivity by oxidation of Fe2+ in the presence of xylenol orange. Free Radic Res 1999; 31: 237–44.
Small DM, Coombes JS, Bennett N, Johnson DW, Gobe GC . Oxidative stress, anti-oxidant therapies and chronic kidney disease. Nephrology (Carlton) 2012; 17: 311–21.
Dodd S, Dean O, Copolov DL, Malhi GS, Berk M . N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin Biol Ther 2008; 8: 1955–62.
Baker WL, Anglade MW, Baker EL, White CM, Kluger J, Coleman CI . Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis. Eur J Cardiothorac Surg 2009; 35: 521–7.
Berk M, Malhi GS, Gray LJ, Dean OM . The promise of N-acetylcysteine in neuropsychiatry. Trends Pharmacol Sci 2013; 34: 167–77.
Dodd S, Dean O, Copolov DL, Malhi GS, Berk M . N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin Biol Ther 2008; 8: 1955–62.
Hsu TF, Huang MK, Yu SH, Yen DH, Kao WF, Chen YC, et al. N-acetylcysteine for the prevention of contrast-induced nephropathy in the emergency department. Intern Med 2012; 51: 2709–14.
Demiroren K, Dogan Y, Kocamaz H, Ozercan IH, Ilhan S, Ustundag B, et al. Protective effects of L-carnitine, N-acetylcysteine and genistein in an experimental model of liver fibrosis. Clin Res Hepatol Gastroenterol 2014; 38: 63–72.
Lee JS, McLaughlin S, Collard HR . Comprehensive care of the patient with idiopathic pulmonary fibrosis. Curr Opin Pulm Med 2011; 17: 348–54.
Zhang L, He YL, Li QZ, Hao XH, Zhang ZF, Yuan JX, et al. N-acetylcysteine alleviated silica-induced lung fibrosis in rats by down-regulation of ROS and mitochondrial apoptosis signaling. Toxicol Mech Methods 2014; 24: 212–9.
Zhou CF, Yu JF, Zhang JX, Jiang T, Xu SH, Yu QY, et al. N-acetylcysteine attenuates subcutaneous administration of bleomycin-induced skin fibrosis and oxidative stress in a mouse model of scleroderma. Clin Exp Dermatol 2013; 38: 403–9.
LeBleu VS, Taduri G, O'Connell J, Teng Y, Cooke VG, Woda C, et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 2013; 19: 1047–53.
Acknowledgements
This research was financially supported by the National Natural Science Foundation of China (No 81470591, 81170636) to Li-min LU, and (No 81100531) to Wei ZHANG.
Author information
Authors and Affiliations
Corresponding author
PowerPoint slides
Rights and permissions
About this article
Cite this article
Shen, Y., Miao, Nj., Xu, Jl. et al. N-acetylcysteine alleviates angiotensin II-mediated renal fibrosis in mouse obstructed kidneys. Acta Pharmacol Sin 37, 637–644 (2016). https://doi.org/10.1038/aps.2016.12
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2016.12
Keywords
This article is cited by
-
Protective effects of interleukin-22 on oxalate-induced crystalline renal injury via alleviating mitochondrial damage and inflammatory response
Applied Microbiology and Biotechnology (2022)
-
NF-E2-Related Factor 2 Suppresses Intestinal Fibrosis by Inhibiting Reactive Oxygen Species-Dependent TGF-β1/SMADs Pathway
Digestive Diseases and Sciences (2018)
-
A peptide vaccine targeting angiotensin II attenuates the cardiac dysfunction induced by myocardial infarction
Scientific Reports (2017)
-
NDRG2 knockdown promotes fibrosis in renal tubular epithelial cells through TGF-β1/Smad3 pathway
Cell and Tissue Research (2017)
-
Molecular analysis of oxalate-induced endoplasmic reticulum stress mediated apoptosis in the pathogenesis of kidney stone disease
Journal of Physiology and Biochemistry (2017)
